Until a few months ago, few if any senior executives had personal experience managing a company during a pandemic. Making matters more difficult, there’s really no recent history to consult to determine what perils lie ahead, which processes worked, which didn’t, and how to plan for a recovery once the crisis passes. Unfortunately, this uncertain environment seems likely to continue for the foreseeable future.
Continue ReadingBARBARA A. BINZAK BLUMENFELD PH.D.Shareholder, Buchanan Ingersoll & Rooney Barbara’s Background Dr.
Continue ReadingAs the number of COVID-19 cases continue to increase worldwide, numerous questions and a tremendous amount of misinformation cloud the issue. Many remain confused about how the virus is transmitted, how dangerous it is, and what treatments for it may be available. The good news is that the safety of our food has been given a clean bill of health so far. Research indicates that food and food ingredients aren’t a transfer source for coronavirus.
Continue ReadingWhile U.S. product recalls were relatively flat from the second to third quarter, expect an upsurge in the weeks and months to come as regulators – under growing pressure from Congress and consumer groups – turn their attention to currently unregulated categories. Part of that pressure on regulators is a result of past handling of product safety issues.
Continue Reading